Neida Conrad

Dr. Neida Conrad


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2021 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
RPRenan E. A. Piraine
Renan E. A. Piraine
VGVitória Sequeira Gonçalves
Vitória Sequeira Gonçalves
AJAlceu Gonçalves dos Santos Junior
Alceu Gonçalves dos Santos Junior
RCRodrigo Cunha
Rodrigo Cunha
PAPedro Machado Medeiros de Albuquerque
Pedro Machado Medeiros de Albuquerque
FLFabio Leite
Fabio Leite

4 July 2025 in Veterinary Vaccine
Verified
Journal Article
Open access
NCNeida Conrad
Neida Conrad
VZVitória Sequeira Gonçalves Zorzi
Vitória Sequeira Gonçalves Zorzi
IMIlana Mazzoleni
Ilana Mazzoleni
Ana Vitória Costa¹Ana Vitória Costa¹
Ana Vitória Costa¹
RPRenan Eugênio Araújo Piraine
Renan Eugênio Araújo Piraine
FLFabio Leite
Fabio Leite

1 January 2021 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
MRMatheus Costa da Rosa
Matheus Costa da Rosa
NCNeida Conrad
Neida Conrad
CMCarina Martins Moraes
Carina Martins Moraes
LRLeandro Do Monte Ribas
Leandro Do Monte Ribas
CNCarlos Eduardo Wayne Nogueira
Carlos Eduardo Wayne Nogueira
FLFabio Leite
Fabio Leite

1 January 2024 in Revista Brasileira de Parasitologia Veterinária
Verified
Journal Article
Open access
PDF file
NCNeida Conrad
Neida Conrad
VZVitória Sequeira Gonçalves Zorzi
Vitória Sequeira Gonçalves Zorzi
NPNatália Berne Pinheiro
Natália Berne Pinheiro
JBJéssica Lopes Borchard
Jéssica Lopes Borchard
MMMicaele Quintana de Moura
Micaele Quintana de Moura
FLFabio Leite
Fabio Leite
The cytokine microenvironment is crucial in generating and polarizing the immune response. A means of monitoring this environment would be of great value for better understanding Toxocara canis immune modulation. The aim of this study was to analyze the dynamics of cytokine transcription ex vivo, during early (24-48 hours) and late (15-30 days) times post-infection, in the mesenteric lymph nodes, spleen and intestinal mucosa of Balb/c mice experimentally infected with T. canis larvae. Mice in the treated group were infected with 100 third-stage larvae (L3), whereas mice in the control group were not infected. Analyses were performed at different times: 24-48 hours post-infection (HPI), 15-30 days post-infection (DPI). IL4, IL10, IL12 and Ym1 mRNA transcriptions were analyzed through qPCR. This study showed cytokine transcription mediated by migrating larvae in the mesenteric lymph nodes and spleen at 24-48 HPI, whereas cytokine transcription in the intestinal mucosa was observed only at late times (15-30 DPI). These results suggest that the T. canis larvae migration during infection might play a role in cytokine dynamics. Since the cytokine microenvironment is crucial in modulating immune response, knowledge of cytokine dynamics during T. canis infections pave the way to better understand its interaction with the host.

1 March 2021 in Journal of Medical Microbiology
Verified
Journal Article
Closed access
MSMarcelle Moura Silveira
Marcelle Moura Silveira
PSPedro Augusto Crespo da Silva
Pedro Augusto Crespo da Silva
NCNeida Conrad
Neida Conrad
TOThaís Larré Oliveira
Thaís Larré Oliveira
DHDaiane Drawanz Hartwig
Daiane Drawanz Hartwig
CTCaroline Trotter
Caroline Trotter
Invasive meningococcal disease (IMD) is a major cause of meningitis and septicaemia worldwide. The switches in serogroup predominance contribute to the unpredictable nature of the disease with significant health impacts. The aim of this study was to determine the epidemiological profile of IMD in Rio Grande do Sul, Santa Catarina and Paraná, three states in the south of Brazil. All meningitis cases confirmed by clinical and/or laboratory criteria notified to the national information system for notifiable diseases between 2015 and 2019 were analysed. Proportions of serogroup and incidence by age were calculated. A total of 17 894 cases of IMD were reported during this period. Of these, 9029 cases (50 %) were due to serogroup C. Furthermore, serogroup W was responsible for almost half of the cases among children younger than 5 years old during 2017 and 2018, with an overall incidence of 33.3 cases per 100 000 infants. Despite the reduction in serogroup C after the introduction of meningococcal C conjugate vaccine into a childhood immunization programme in Brazil, it remains a significant healthcare issue in the south of the country. Changes in disease epidemiology were observed and serogroup W was the most common among children below 5 years of age in 2017 and 2018. Although future cost-effectiveness studies are necessary, our results could have future implications for meningococcal vaccination programmes.

1 January 2025 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
PDF file
NCNeida Conrad
Neida Conrad
VZVitória Sequeira Gonçalves Zorzi
Vitória Sequeira Gonçalves Zorzi
FSFrancisco Denis Souza Santos
Francisco Denis Souza Santos
CGCésar Graner
César Graner
MSMarcelle Moura Silveira
Marcelle Moura Silveira
FLFabio Leite
Fabio Leite
The use of passive immunization could be a strategy for the control of SARS-CoV-2 infections. Our study proposes to produce anti-SARS-CoV-2 antibodies from the immunization of horses, and purify F(ab’)2 fragment aiming to provide a therapy capable of acting in the treatment of infections, prevention, and control of COVID-19 outbreaks. To produce hyperimmune sera animals were inoculated with SARS-CoV-2 inactivated viral particles added with Freund's or aluminum hydroxide as adjuvant. Antibodies level was determined by indirect ELISA using the inactivated SARS-CoV-2 virus. Independent of the adjuvant used, a specific antibody anti-SARS-CoV-2 were detected from the second inoculation up to 4 months. The presence of neutralizing antibodies was observed from the third dose and was maintained until day 110 of the experiment. The antibodies fragmentation process was able to produce F(ab’)2 fragments and maintained the antibody ability to recognize, bind and neutralize the antigen in vitro. To evaluate the safety and effect of antibodies in vivo, we transferred the equine F(ab’)2 antibodies to mice. Mice remained healthy and equine anti-SARS-CoV-2 antibodies were detected in sera. Anti-SARS-CoV-2 antibodies obtained are able to neutralize SARS-CoV-2 virus and are highlighted as a potential therapeutic option for the COVID-19 treatment.